학술논문
Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System
Document Type
Article
Author
Source
In: Therapeutic Advances in Neurological Disorders . (Therapeutic Advances in Neurological Disorders, 2022, 15)
Subject
Language
English
ISSN
17562864
17562856
17562856